Charles K. Lumpkin

4.0k total citations
69 papers, 3.4k citations indexed

About

Charles K. Lumpkin is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Charles K. Lumpkin has authored 69 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 22 papers in Genetics and 16 papers in Epidemiology. Recurrent topics in Charles K. Lumpkin's work include Bone Metabolism and Diseases (14 papers), Bone fractures and treatments (13 papers) and Craniofacial Disorders and Treatments (11 papers). Charles K. Lumpkin is often cited by papers focused on Bone Metabolism and Diseases (14 papers), Bone fractures and treatments (13 papers) and Craniofacial Disorders and Treatments (11 papers). Charles K. Lumpkin collaborates with scholars based in United States and Sweden. Charles K. Lumpkin's co-authors include Kathryn M. Thrailkill, John L. Fowlkes, R. Clay Bunn, Thomas M. Badger, James R. Smith, Martin J. J. Ronis, James Aronson, Gael Cockrell, Stephen F. Kemp and J. Keith McClung and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Charles K. Lumpkin

68 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles K. Lumpkin United States	34	1.8k	695	635	565	527	69	3.4k
Gianluca Toraldo United States	18	1.8k 1.0×	578 0.8×	1.0k 1.6×	639 1.1×	340 0.6×	27	3.1k
Stuart H. Ralston United Kingdom	29	1.7k 1.0×	1.2k 1.8×	915 1.4×	607 1.1×	136 0.3×	49	3.2k
Paula H. Stern United States	37	1.9k 1.1×	772 1.1×	1.4k 2.3×	566 1.0×	182 0.3×	163	4.4k
Ruth McCracken United States	25	1.3k 0.7×	385 0.6×	444 0.7×	405 0.7×	117 0.2×	28	3.1k
Fei‐Yan Deng China	27	1.3k 0.7×	554 0.8×	407 0.6×	452 0.8×	207 0.4×	145	2.7k
Ichiro Takada Japan	23	2.0k 1.1×	220 0.3×	483 0.8×	433 0.8×	306 0.6×	50	3.8k
Hollis A. Simmons United States	33	2.0k 1.1×	1.0k 1.5×	1.6k 2.6×	928 1.6×	136 0.3×	52	4.0k
G V Segre United States	33	2.2k 1.3×	496 0.7×	1.6k 2.5×	597 1.1×	97 0.2×	61	4.2k
Stavroula Kousteni United States	36	3.5k 2.0×	1.5k 2.1×	1.9k 3.0×	1.5k 2.6×	344 0.7×	62	6.6k
A C Moses United States	27	1.4k 0.8×	346 0.5×	427 0.7×	379 0.7×	121 0.2×	49	3.1k

Countries citing papers authored by Charles K. Lumpkin

Since Specialization

Citations

This map shows the geographic impact of Charles K. Lumpkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles K. Lumpkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles K. Lumpkin more than expected).

Fields of papers citing papers by Charles K. Lumpkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles K. Lumpkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles K. Lumpkin. The network helps show where Charles K. Lumpkin may publish in the future.

Co-authorship network of co-authors of Charles K. Lumpkin

This figure shows the co-authorship network connecting the top 25 collaborators of Charles K. Lumpkin. A scholar is included among the top collaborators of Charles K. Lumpkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles K. Lumpkin. Charles K. Lumpkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thrailkill, Kathryn M., Jeffry S. Nyman, R. Clay Bunn, et al.. (2016). The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes. Bone. 94. 141–151. 56 indexed citations

Stine, Kimo C., Elizabeth C. Wahl, Lichu Liu, et al.. (2016). Nutlin‐3 treatment spares cisplatin‐induced inhibition of bone healing while maintaining osteosarcoma toxicity. Journal of Orthopaedic Research®. 34(10). 1716–1724. 6 indexed citations

Thrailkill, Kathryn M., R. Clay Bunn, Jeffry S. Nyman, et al.. (2015). SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice. Bone. 82. 101–107. 63 indexed citations

Mercer, Kelly E., Clark Sims, Rebecca Wynne, et al.. (2013). Loss of Functional NADPH Oxidase 2 Protects Against Alcohol‐Induced Bone Resorption in Female p47phox^−/− Mice. Alcoholism Clinical and Experimental Research. 38(3). 672–682. 23 indexed citations

Stine, Kimo C., Elizabeth C. Wahl, Lichu Liu, et al.. (2013). Cisplatin inhibits bone healing during distraction osteogenesis. Journal of Orthopaedic Research®. 32(3). 464–470. 29 indexed citations

Mercer, Kelly E., Rebecca Wynne, Oxana P. Lazarenko, et al.. (2012). Vitamin D Supplementation Protects against Bone Loss Associated with Chronic Alcohol Administration in Female Mice. Journal of Pharmacology and Experimental Therapeutics. 343(2). 401–412. 38 indexed citations

Fowlkes, John L., R. Clay Bunn, Gael Cockrell, et al.. (2011). Dysregulation of the Intrarenal Vitamin D Endocytic Pathway in a Nephropathy-Prone Mouse Model of Type 1 Diabetes. Experimental Diabetes Research. 2011. 1–7. 30 indexed citations

Nyman, Jeffry S., Jesse L. Even, Chan‐Hee Jo, et al.. (2010). Increasing duration of type 1 diabetes perturbs the strength–structure relationship and increases brittleness of bone. Bone. 48(4). 733–740. 89 indexed citations

Chen, Jin‐Ran, Oxana P. Lazarenko, Kartik Shankar, et al.. (2010). Inhibition of NADPH Oxidases Prevents Chronic Ethanol-Induced Bone Loss in Female Rats. Journal of Pharmacology and Experimental Therapeutics. 336(3). 734–742. 50 indexed citations

10.

Thrailkill, Kathryn M., Cynthia Moreau, Gael Cockrell, et al.. (2010). Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine. 37(2). 336–343. 57 indexed citations

11.

Wahl, Elizabeth C., James Aronson, Lichu Liu, et al.. (2009). Direct bone formation during distraction osteogenesis does not require TNFα receptors and elevated serum TNFα fails to inhibit bone formation in TNFR1 deficient mice. Bone. 46(2). 410–417. 15 indexed citations

12.

Liu, Zhendong, James Aronson, Elizabeth C. Wahl, et al.. (2007). A novel rat model for the study of deficits in bone formation in type-2 diabetes. Acta Orthopaedica. 78(1). 46–55. 40 indexed citations

13.

Fowlkes, John L., R. Clay Bunn, Lichu Liu, et al.. (2007). Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus. Endocrinology. 149(4). 1697–1704. 93 indexed citations

14.

Chen, Jin‐Ran, Mats Hidestrand, Kartik Shankar, et al.. (2006). Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-κB Ligand in Osteoblasts. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1182–1190. 53 indexed citations

15.

Wahl, Elizabeth C., Daniel S. Perrien, James Aronson, et al.. (2005). Ethanol-Induced Inhibition of Bone Formation in a Rat Model of Distraction Osteogenesis: A Role for the Tumor Necrosis Factor Signaling Axis. Alcoholism Clinical and Experimental Research. 29(8). 1466–1472. 14 indexed citations

16.

Aronson, James, Zhaoyang Liu, Daniel S. Perrien, et al.. (2002). Decreased Endosteal Intramembranous Bone Formation Accompanies Aging in a Mouse Model of Distraction Osteogenesis. 3(2). 7–16. 15 indexed citations

17.

Aronson, James, Xiaodong Shen, R. A. Skinner, et al.. (1997). Rat model of distraction osteogenesis. Journal of Orthopaedic Research®. 15(2). 221–226. 74 indexed citations

18.

Nuell, Mark J., David A. Stewart, Lisa Walker, et al.. (1991). Prohibitin, an Evolutionarily Conserved Intracellular Protein That Blocks DNA Synthesis in Normal Fibroblasts and HeLa Cells. Molecular and Cellular Biology. 11(3). 1372–1381. 56 indexed citations

19.

Henle, Kurt J., et al.. (1990). Expression of thermotolerance following microinjection of poly(A)RNA isolated from thermotolerant CHO cells. International Journal of Hyperthermia. 6(6). 1041–1051. 2 indexed citations

20.

Jones, Richard B., Charles K. Lumpkin, & James R. Smith. (1980). Discrete digital simulation of a genetic control theory. Annual Simulation Symposium. 45–58.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact